Enhanced proteolytic activity achieved through use of Trypsin/Lys-C Mix can result in a 20-40% increase in the number of peptides generated, enabling a higher number of proteins to be identified. Trypsin/Lys-C Mix is also tolerant to Trypsin-inhibiting contaminants, enabling researchers to generate mass spectrometry data from poor-quality sample material such as FFPE sections.
Many proteins are resistant to trypsin due to tight conformation, and although protein denaturation enables proteolysis, trypsin is inactive under these conditions. Promega’s Trypsin/Lys-C Mix overcomes this barrier as it remains active even under strong denaturing conditions, enabling digestion of even proteolytically resistant proteins.
For more information about Promega’s Trypsin/Lys-C Mix please visit: www.promega.com/tryplys
Promega has been a market leader in providing Trypsin and alternative proteases for mass spectrometry analysis for over 15 years.
For a high resolution image please contact Zyme Communications
Contacts:
Penny Patterson
Sr. Director, Communications
Promega Corporation
Phone: (608) 274-4330
E-mail: penny.patterson@promega.com
Katie Odgaard
Zyme Communications Ltd
Tel: +44 (0) 7787 502 947
Email: katie.odgaard@zymecommunications.com
Skype: kodgaard
www.zymecommunications.com
About Promega
Promega Corporation is a leader in providing innovative solutions and technical support to the life sciences industry. The company’s 2,500 products enable scientists worldwide to advance their knowledge in genomics, proteomics, cellular analysis, molecular diagnostics and human identification. Founded in 1978, the company is headquartered in Madison, WI, USA with branches in 15 countries and over 50 global distributors. For more information about Promega, visit www.promega.com.
